IMUNON Announces New Immunogenicity Data from Phase 1 Clinical Trial of Its DNA Vaccine in Treatment of COVID-19
Results of IMNN-101 Proof-of-Concept study demonstrate persistent immunogenicity in trial participants and further validate PlaCCine® ...
Taysha Gene Therapies Reports Full-Year 2024 Financial Results and Provides Corporate Update
High dose and low dose of TSHA-102 continue to be generally well tolerated with no treatment-related SAEs or DLTs in all pediatric, adolescent ...
hero-magazine.com7h
Gucci’s in-house team reimagined archive icons
With Sabato De Sarno’s surprise exit from the brand earlier this month, this season’s Gucci show was left in the capable hands of the in-house design team. This was the design team’s second outing in ...